Law360, New York (June 4, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration is considering adding suicide warnings to a large class of blockbuster epilepsy drugs after a damaging agency report, regulators said in a meeting with industry representatives Monday.
The Epilepsy Study Consortium hosted a closed-door meeting to discuss clinical trial design on Monday. There, the FDA reiterated to academics and company representatives its concerns that epilepsy drugs promote suicidal thoughts in patients, an FDA spokeswoman said.
The FDA initially issued a warning on Jan. 31 to alert health care professionals to...
FDA Links Suicide And Epilepsy Drugs
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
